Non-Current Liabilities
Vertex Pharmaceuticals·Balance Sheet Statement·3 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total liabilities | $5.4B | $6.6B | $6.1B | $6.4B | $6.9B | $7.5B | $7B | $7.1B |
| Operating lease liabilities, non-current | $586.8M | $1.6B | $1.5B | $1.5B | $1.5B | $1.8B | $1.8B | $2B |
| Other non-current liabilities | $876.8M | $933.3M | $1B | $951.9M | $1.2B | $1.2B | $1.3B | $1.3B |